Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GNA13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MUT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AKIRIN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YIPF5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCORL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGFG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMARCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GTF2H1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF470 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CYFIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRPF40A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HM13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHD4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FZD5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EXOC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTDP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SF3B1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EHMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KLK15 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on